Drug-maker Sun Pharmaceutical Industries gained over 3% on the bourses today after the company reported 19% growth in net profit to Rs 598 crore for the quarter ended September 30.
Shares of the company jumped by 3.4% to Rs 521 on the BSE, while on the NSE, the scrip gained 3.5% to Rs 522.
The drug-maker's scrip was also the top gainer among the Sensex-30 blue-chips in morning trade.
Sun Pharmaceutical Industries has reported 19% growth in net profit to Rs 598 crore for the quarter ended September 30 on account of robust performance across its businesses.
In the corresponding year-ago period, the company had posted a net profit of Rs 503.65 crore.
On a standalone basis, Sun Pharma's net profit increased to Rs 437.55 crore in the second quarter ended September 30 from Rs 345.72 crore in the year-ago period.
